220 related articles for article (PubMed ID: 9797863)
1. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.
McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ
Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863
[TBL] [Abstract][Full Text] [Related]
2. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
4. Drug inducible transgene expression in brain using a herpes simplex virus vector.
Oligino T; Poliani PL; Wang Y; Tsai SY; O'Malley BW; Fink DJ; Glorioso JC
Gene Ther; 1998 Apr; 5(4):491-6. PubMed ID: 9614573
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors.
Wood MJ; Byrnes AP; Pfaff DW; Rabkin SD; Charlton HM
Gene Ther; 1994 Sep; 1(5):283-91. PubMed ID: 7584093
[TBL] [Abstract][Full Text] [Related]
6. Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting.
Wood MJ; Byrnes AP; Kaplitt MG; Pfaff DW; Rabkin SD; Charlton HM
Exp Neurol; 1994 Nov; 130(1):127-40. PubMed ID: 7821388
[TBL] [Abstract][Full Text] [Related]
7. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
8. HSV vector-mediated gene delivery to the central nervous system.
Maguire-Zeiss KA; Bowers WJ; Federoff HJ
Curr Opin Mol Ther; 2001 Oct; 3(5):482-90. PubMed ID: 11699893
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer into the central nervous system using herpes simplex virus-1 vectors.
Tabbaa S; Goulah C; Tran RK; Lis A; Korody R; Stachowski B; Horowitz JM; Torres G; Stachowiak EK; Bloom DC; Stachowiak MK
Folia Morphol (Warsz); 2000; 59(4):221-32. PubMed ID: 11107692
[TBL] [Abstract][Full Text] [Related]
10. Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.
Herrlinger U; Kramm CM; Aboody-Guterman KS; Silver JS; Ikeda K; Johnston KM; Pechan PA; Barth RF; Finkelstein D; Chiocca EA; Louis DN; Breakefield XO
Gene Ther; 1998 Jun; 5(6):809-19. PubMed ID: 9747461
[TBL] [Abstract][Full Text] [Related]
11. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
Yang T; Wang X; Yan Z; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234
[TBL] [Abstract][Full Text] [Related]
12. Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector.
Kamiyama H; Kurimoto M; Yamamura J; Uwano T; Hirashima Y; Kurokawa M; Endo S; Shiraki K
Gene Ther; 2001 Aug; 8(15):1180-7. PubMed ID: 11509949
[TBL] [Abstract][Full Text] [Related]
13. Use of herpes simplex virus type 1 for transgene expression within the nervous system.
Lachmann RH; Efstathiou S
Clin Sci (Lond); 1999 Jun; 96(6):533-41. PubMed ID: 10334958
[TBL] [Abstract][Full Text] [Related]
14. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
[TBL] [Abstract][Full Text] [Related]
15. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes.
Wang S; Ma N; Gao SJ; Yu H; Leong KW
Mol Ther; 2001 May; 3(5 Pt 1):658-64. PubMed ID: 11356070
[TBL] [Abstract][Full Text] [Related]
16. Dynamic of migration of HSV-1 from a medullary pronociceptive centre: antinociception by overexpression of the preproenkephalin transgene.
Martins I; Pinto M; Wilson SP; Lima D; Tavares I
Eur J Neurosci; 2008 Nov; 28(10):2075-83. PubMed ID: 19046388
[TBL] [Abstract][Full Text] [Related]
17. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.
Howard MK; Kershaw T; Gibb B; Storey N; MacLean AR; Zeng BY; Tel BC; Jenner P; Brown SM; Woolf CJ; Anderson PN; Coffin RS; Latchman DS
Gene Ther; 1998 Aug; 5(8):1137-47. PubMed ID: 10326038
[TBL] [Abstract][Full Text] [Related]
18. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
19. Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector.
Yamamura J; Kageyama S; Uwano T; Kurokawa M; Imakita M; Shiraki K
Gene Ther; 2000 Jun; 7(11):934-41. PubMed ID: 10849553
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus-mediated gene delivery to the rodent visual system.
Spencer B; Agarwala S; Miskulin M; Smith M; Brandt CR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1392-401. PubMed ID: 10798655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
